BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 15104237)

  • 1. Oxidized LDL-dependent pathway as new pathogenic trigger in arrhythmogenic cardiomyopathy.
    Sommariva E; Stadiotti I; Casella M; Catto V; Dello Russo A; Carbucicchio C; Arnaboldi L; De Metrio S; Milano G; Scopece A; Casaburo M; Andreini D; Mushtaq S; Conte E; Chiesa M; Birchmeier W; Cogliati E; Paolin A; König E; Meraviglia V; De Musso M; Volani C; Cattelan G; Rauhe W; Turnu L; Porro B; Pedrazzini M; Camera M; Corsini A; Tondo C; Rossini A; Pompilio G
    EMBO Mol Med; 2021 Sep; 13(9):e14365. PubMed ID: 34337880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 9- and 13-HODE regulate fatty acid binding protein-4 in human macrophages, but does not involve HODE/GPR132 axis in PPAR-γ regulation of FABP4.
    Vangaveti V; Shashidhar V; Collier F; Hodge J; Rush C; Malabu U; Baune B; Kennedy RL
    Ther Adv Endocrinol Metab; 2018 May; 9(5):137-150. PubMed ID: 29796244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxyoctadecadienoic acids: novel regulators of macrophage differentiation and atherogenesis.
    Vangaveti V; Baune BT; Kennedy RL
    Ther Adv Endocrinol Metab; 2010 Apr; 1(2):51-60. PubMed ID: 23148150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA polymerase β variant Ile260Met generates global gene expression changes related to cellular transformation.
    Donigan KA; Tuck D; Schulz V; Sweasy JB
    Mutagenesis; 2012 Nov; 27(6):683-91. PubMed ID: 22914675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociation of apoptosis induction and CD36 upregulation by enzymatically modified low-density lipoprotein in monocytic cells.
    Jostarndt K; Gellert N; Rubic T; Weber C; Kühn H; Johansen B; Hrboticky N; Neuzil J
    Biochem Biophys Res Commun; 2002 Jan; 290(3):988-93. PubMed ID: 11798172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degree of oxidation of low density lipoprotein affects expression of CD36 and PPARgamma, but not cytokine production, by human monocyte-macrophages.
    Kavanagh IC; Symes CE; Renaudin P; Nova E; Mesa MD; Boukouvalas G; Leake DS; Yaqoob P
    Atherosclerosis; 2003 Jun; 168(2):271-82. PubMed ID: 12801610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonistic effects of oxidized low density lipoprotein and alpha-tocopherol on CD36 scavenger receptor expression in monocytes: involvement of protein kinase B and peroxisome proliferator-activated receptor-gamma.
    Munteanu A; Taddei M; Tamburini I; Bergamini E; Azzi A; Zingg JM
    J Biol Chem; 2006 Mar; 281(10):6489-97. PubMed ID: 16407258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-density lipoprotein inhibits the uptake of modified low- density lipoprotein and the expression of CD36 and FcgammaRI.
    Carvalho MD; Vendrame CM; Ketelhuth DF; Yamashiro-Kanashiro EH; Goto H; Gidlund M
    J Atheroscler Thromb; 2010 Aug; 17(8):844-57. PubMed ID: 20467189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of PPAR-gamma in the modulation of CD36 and FcgammaRII induced by LDL with low and high degrees of oxidation during the differentiation of the monocytic THP-1 cell line.
    Rios FJ; Jancar S; Melo IB; Ketelhuth DF; Gidlund M
    Cell Physiol Biochem; 2008; 22(5-6):549-56. PubMed ID: 19088437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzymatically modified low-density lipoprotein upregulates CD36 in low-differentiated monocytic cells in a peroxisome proliferator-activated receptor-gamma-dependent way.
    Jostarndt K; Rubic T; Kuhn H; Anthosen MW; Andera L; Gellert N; Trottman M; Weber C; Johansen B; Hrboticky N; Neuzil J
    Biochem Pharmacol; 2004 Mar; 67(5):841-54. PubMed ID: 15104237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CD36 in macrophages and atherosclerosis: the role of lipid regulation of PPARgamma signaling.
    Nicholson AC
    Trends Cardiovasc Med; 2004 Jan; 14(1):8-12. PubMed ID: 14720468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of CD36, the macrophage class B scavenger receptor, in atherosclerosis.
    Nicholson AC; Han J; Febbraio M; Silversterin RL; Hajjar DP
    Ann N Y Acad Sci; 2001 Dec; 947():224-8. PubMed ID: 11795270
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.